Skip to main content

Table 3 Conditions reported as reasons for using medical cannabis

From: Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)

Condition

Rank

Main conditiona (n = 1331)

Any conditionb (n = 1382)

Condition

n (%)c

Condition

n (%)c

Pain

 

Total

499 (37.5%)

Total

852 (61.6%)

1

Back pain

135 (10.1%)

Back pain

477 (34.5%)

2

Arthritis

79 (5.9%)

Arthritis

262 (19.0%)

3

Nerve pain

75 (5.6%)

Headaches

215 (15.6%)

4

Fibromyalgia

52 (3.9%)

Neck pain

202 (14.6%)

5

All others

158 (12.0%)

All others

638 (46.1%)

Mental health

 

Total

437 (32.8%)

Total

621 (44.9%)

1

Anxiety

168 (12.6%)

Anxiety

450 (32.6%)

2

Depression

113 (8.5%)

Depression

386 (27.9%)

3

PTSD

82 (6.2%)

PTSD

191 (13.8%)

4

Bipolar affective disorder

15 (1.1%)

Addiction to other substances

67 (4.8%)

5

All others

59 (4.5%)

All others

198 (14.3%)

Sleep

 

Total

123 (9.2%)

Total

679 (49.1%)

1

Insomnia

94 (7.1%)

Insomnia

573 (41.5%)

2

Circadian rhythm disorder

9 (0.7%)

Sleep movement disorder

140 (10.1%)

3

Sleep movement disorder

9 (0.7%)

Circadian rhythm disorder

74 (5.4%)

4

Parasomnia

1 (0.1%)

Sleep breathing disorder

55 (4.0%)

5

All others

10 (0.8%)

All others

70 (5.1%)

Neurological

 

Total

69 (5.2%)

Total

147 (10.6%)

1

Epilepsy

26 (2.0%)

Epilepsy

45 (3.3%)

2

Autism

14 (1.1%)

Autism

27 (2.0%)

3

Multiple Sclerosis

13 (1.0%)

Multiple Sclerosis

18 (1.3%)

4

Dementia

1 (0.1%)

Dementia

6 (0.4%)

5

All others

15 (1.2%)

All others

71 (5.2%)

Cancer

 

Total

50 (3.8%)

Total

106 (7.7%)

1

Blood cancers

8 (0.6%)

Breast

19 (1.4%)

2

Gastrointestinal cancers

6 (0.5%)

Skin

17 (1.2%)

3

Brain

5 (0.4%)

Brain

15 (1.1%)

4

Breast

5 (0.4%)

Reproductive

15 (1.1%)

5

All others

26 (2.1%)

All others

57 (4.1%)

Gastrointestinald

 

Total

40 (3.0%)

Total

175 (12.7%)

1

Crohn’s disease

10 (0.8%)

Irritable Bowel Syndrome

101 (7.3%)

2

Ulcerative colitis

10 (0.8%)

Ulcerative Collitis

25 (1.8%)

3

Irritable Bowel syndrome

9 (0.7%)

Crohn’s Disease

19 (1.4%)

4

All others

11 (0.8%)

All others

60 (4.3%)

Other

 

Total

113 (8.5%)

Total

165 (11.9%)

1

Auto-immune condition

33 (2.5%)

Auto-immune condition

64 (4.6%)

2

Gynaecological condition

25 (1.9%)

Skin condition

43 (3.1%)

3

Infectious disease

9 (0.7%)

Respiratory conditions

41 (3.0%)

4

Skin condition

9 (0.7%)

Gynaecological condition

31 (2.2%)

5

All others

37 (2.9%)

All others

88 (6.5%)

  1. aRespondents could only select one main condition that they treated with cannabis
  2. bRespondents could select up to five conditions that they treated with cannabis
  3. cPercentages displayed represent the proportion each specific category makes up of the entire available sample (i.e. n/1331 for main condition and n/1382 for any condition)
  4. dThere were only three specific conditions listed under the gastrointestinal group, and an ‘other’ category